| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Martin Vogelbaum last filed a Form 4 in June 2024, as Director at TVRD. Martin Vogelbaum's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 411,007 shares of TVRD. Net of sales, the TVRD filings show accumulation of 374,560 shares.
Martin Vogelbaum has 14 Form 4 filings on record from June 2015 to June 2024, across 2 companies: Director at Tvardi Therapeutics (TVRD), 2015–2024; Director at Rocket Pharmaceuticals (RCKT), 2015.
The 23 reported transactions were 11 option or other derivative awards, 7 stock awards, 3 open-market sales and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $1.9M and 3 sales worth about $320K.
The only open-market purchase was 400,000 shares of TVRD at an average $4.87 on March 17, 2016, about $1.9M.
The largest open-market sale was 8,640 shares of TVRD at an average $13.05 on June 7, 2021, about $113K. Twelve months later TVRD was down 34%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 10,800 | $10.28 | $111,024.00 | -19.4% | +12.2% | -79.9% | |
| Jun 7, 2021 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 8,640 | $13.05 | $112,752.00 | -30.0% | +16.0% | -34.1% | |
| Nov 17, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 6,000 | $16.09 | $96,540.00 | -29.4% | - | - | |
| Mar 17, 2016 | TVRD Tvardi Therapeutics, Inc. | Director | Buy | 400,000 | $4.87 | $1,949,202.91 | +15.0% | - | - |